Japanese Pharmaceuticals & Biotech High Growth Potential Companies

GNI Group

Market Cap: JP¥131.3b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥20.1b

Engages in the regenerative medicine business in Japan.

Kidswell Bio

Market Cap: JP¥11.9b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Chugai Pharmaceutical

Market Cap: JP¥11.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Takara Bio

Market Cap: JP¥114.6b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

PeptiDream

Market Cap: JP¥196.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Nxera Pharma

Market Cap: JP¥88.5b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Sawai Group Holdings

Market Cap: JP¥226.2b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥68.3b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Sumitomo Pharma

Market Cap: JP¥698.8b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Daiichi Sankyo Company

Market Cap: JP¥6.7t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

JCR Pharmaceuticals

Market Cap: JP¥79.9b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Zeria Pharmaceutical

Market Cap: JP¥88.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.